- Home
- STSS vs NDRA Comparison
STSS vs NDRA Comparison
Compare STSS & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STSS
- NDRA
- Stock Information
- Founded
- STSS 2017
- NDRA 2007
- Country
- STSS United States
- NDRA United States
- Employees
- STSS N/A
- NDRA N/A
- Industry
- STSS Medical/Dental Instruments
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- STSS Health Care
- NDRA Health Care
- Exchange
- STSS Nasdaq
- NDRA Nasdaq
- Market Cap
- STSS 3.0M
- NDRA 3.0M
- IPO Year
- STSS 2022
- NDRA 2017
- Fundamental
- Price
- STSS $0.32
- NDRA $4.89
- Analyst Decision
- STSS
- NDRA Strong Buy
- Analyst Count
- STSS 0
- NDRA 1
- Target Price
- STSS N/A
- NDRA $14,000.00
- AVG Volume (30 Days)
- STSS 2.4M
- NDRA 20.1K
- Earning Date
- STSS 03-31-2025
- NDRA 03-27-2025
- Dividend Yield
- STSS N/A
- NDRA N/A
- EPS Growth
- STSS N/A
- NDRA N/A
- EPS
- STSS N/A
- NDRA N/A
- Revenue
- STSS N/A
- NDRA N/A
- Revenue This Year
- STSS N/A
- NDRA N/A
- Revenue Next Year
- STSS N/A
- NDRA N/A
- P/E Ratio
- STSS N/A
- NDRA N/A
- Revenue Growth
- STSS N/A
- NDRA N/A
- 52 Week Low
- STSS $0.30
- NDRA $4.01
- 52 Week High
- STSS $18.15
- NDRA $2,240.00
- Technical
- Relative Strength Index (RSI)
- STSS 12.70
- NDRA 40.73
- Support Level
- STSS $0.34
- NDRA $4.80
- Resistance Level
- STSS $0.42
- NDRA $5.65
- Average True Range (ATR)
- STSS 0.13
- NDRA 0.47
- MACD
- STSS -0.15
- NDRA -0.11
- Stochastic Oscillator
- STSS 1.12
- NDRA 12.00
About STSS Sharps Technology Inc.
Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes are designed to eliminate potentially infectious and accidental needlestick injuries.
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.